Vanda Pharmaceuticals: ‘A Major Upside Surprise’

You don't say. Actually, you don't need me or anyone else to tell you that something surprising occurred for Vanda Pharmaceuticals ( VNDA ) because its shares are up nearly 20%. But that's how Piper Jaffray analyst Joshua Schimmer and team described the news that Vanda had won a major patent decision . They explain:
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.